Share this

M-M-R®II

M-M-R®II Product Overview

Global Vaccine Safety
Essential Medicine & Health Products 20, Avenue Appia, CH-1211 Geneva 27
Switzerland

Information Sheet
Observed rate of vaccine reactions
Measles, Mumps and Rubella vaccines2

Contains the Jeryl LynTM (JL) mumps strain3

-No evidence links the JL strain to aseptic meningitis

Choose

A legacy of protection for this generation.

  • Measles, mumps, and rubella are highly contagious diseases4
  • Contributed significant global mortality and morbidity in the pre-vaccine era4
  • Used in >75 countries in helping prevent MMR diseases since over 40 years4
  • The vaccine has been part of immunization programs that have achieved dramatic global reductions in case numbers and mortality rates ias well as the elimination of measles and rubella in several countries and regions4

More about M-M-R®II

Disease

Measles is an infectious disease that is highly contagious with symptoms of high fever, cough, red eyes, and rashes on the skin.

Efficacy Data

M-M-R® II vaccine helping to protect generations of children from 3 childhood disease – measles, mumps, and rubella

References:

  1. Nytimes.com. (2019). A Forgotten Pioneer of Vaccines. [online] Available From: https://www.nytimes.com/2013/05/07/ health/maurice-hilleman-M-M-R-vaccinesforgotten-hero.html?_r=0.
  2. World Health Organization (WHO). Information Sheet Observed Rate of Vaccine Reactions Measles, Mumps, and Rubella Vaccines. Available From:
    https://www.who.int/vaccine_safety/initiative/tools/MMR_vaccine_rates_information_ sheet.pdf.
  3. Lievano F, et al. Measles, mumps, and rubella virus vaccine (M-M-R™II): a review of 32 years of clinical and postmarketingexperience. Vaccine. 2012;30(48):6918–6926.
  4. Kuter BJ, Marshall GS, Fergie J, Schmidt E, Pawaskar M. Prevention of measles, mumps and rubella: 40 years of global experience with M-M-RII. Hum Vaccin Immunother. 2021 Dec 2;17(12):5372-5383. doi: 10.1080/21645515.2021.2007710.

PH-MMR-00015 Oct/2024